Guided Therapeutics (GTHP) Enterprise Value (2010 - 2025)
Guided Therapeutics (GTHP) reported Enterprise Value of -$63000.0 for Q4 2025, up 83.76% on a YoY basis from -$34283.3 in Q4 2024, and up 27.59% sequentially from -$87000.0 in Q3 2025.
Guided Therapeutics (GTHP) Enterprise Value (2010 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 16 years of Enterprise Value data on file, last reported at -$63000.0 in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 83.76% year-over-year to -$63000.0; the trailing twelve-month figure through Dec 2025 stood at -$63000.0 (up 83.76% YoY), and the FY2025 full-year result was -$63000.0, up 83.76% from the prior year.
- Enterprise Value rose to -$63000.0 in Q4 2025, from -$87000.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$63000.0 in Q4 2025 to a low of -$2.7 million in Q3 2022.
- A 5-year average of -$790150.0 and a median of -$566000.0 in 2021 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value plunged 5838.1% in 2021 and surged 83.76% in 2025, its largest moves.
- Tracing GTHP's Enterprise Value over 5 years: stood at -$643000.0 in 2021, then sank by 259.72% to -$2.3 million in 2022, then soared by 74.45% to -$591000.0 in 2023, then soared by 34.35% to -$388000.0 in 2024, then surged by 83.76% to -$63000.0 in 2025.
- Business Quant data shows GTHP's Enterprise Value at -$63000.0 in Q4 2025, -$87000.0 in Q3 2025, and -$185000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | -63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Jun 30, 2025 | -185,000.00 |
| Mar 31, 2025 | -115,000.00 |
| Dec 31, 2024 | -388,000.00 |
| Sep 30, 2024 | -194,000.00 |
| Jun 30, 2024 | -275,000.00 |
| Mar 31, 2024 | -445,000.00 |
| Dec 31, 2023 | -591,000.00 |
| Sep 30, 2023 | -731,000.00 |
| Jun 30, 2023 | -1.36 Mn |
| Mar 31, 2023 | -1.84 Mn |
| Dec 31, 2022 | -2.31 Mn |
| Sep 30, 2022 | -2.70 Mn |
| Jun 30, 2022 | -446,000.00 |
| Mar 31, 2022 | -725,000.00 |
| Dec 31, 2021 | -643,000.00 |
| Sep 30, 2021 | -541,000.00 |
| Jun 30, 2021 | -922,000.00 |
| Mar 31, 2021 | -1.25 Mn |